—FIS
— • —
$43.37
P/E
59.74
PEG
—
FCF Yield
—
Rev Growth YoY
+543.0% YoY
Gross Margin
3686.0%
Health Score
4/10
D/E Ratio
0.94
Confidence
—
Business Snapshot
The ticker and company name were not provided in this data payload, which limits contextual background. Based on the available financial data, this appears to be a company with a Price/Sales ratio of 2.15x and a P/E of 59.74x, suggesting it operates in a growth-oriented segment. Without a confirmed market capitalisation figure, precise cap-tier classification cannot be made, though the valuation profile and data characteristics are consistent with a smaller or emerging-stage company.
Financial Health
**Score: 4/10** The financial health picture is mixed and warrants caution. The gross margin stands at an extraordinary 3,686% and net margin at 357%, which are statistically anomalous figures that likely reflect accounting distortions, one-time items, or non-standard revenue recognition rather than genuine operational efficiency...
Risk Assessment
- **VALUATION: P/E of 59.74x is approximately 2.4x the sector average of 25x, with no PEG or DCF estimate to justify the premium.** - **LIQUIDITY: Current ratio of 0.59x indicates the company may struggle to meet near-term obligations, falling well below the conventional safe threshold of 1.0x.** - **EARNINGS DETERIORATION: Earnings growth of -7,203% year-over-year represents a severe bottom-line collapse that directly contradicts the strong revenue headline.** - **DATA QUALITY: Gross margin of 3,686% and net margin of 357% are statistically implausible for most industries and suggest possible data anomalies, restatements, or non-standard accounting.** - **TECHNICAL WEAKNESS: A confirmed death cross (50-day MA crossing below 200-day MA) combined with a bearish MACD signal indicates prevailing downside momentum in the share price.** ---...